In brief
Defense Secretary Pete Hegseth declared that the U.S. Army will begin a comprehensive testosterone screening initiative, targeting service members 30 and older annually and younger troops upon request. The program offers voluntary replacement therapy for those with deficient hormone levels, with the goal of optimizing performance and career longevity. Medical experts highlight benefits such as increased muscle mass and reduced depression risk, though they caution against unnecessary hormone use. Hegseth underscored that this move is not about artificial enhancement, citing strict prohibitions against non‑prescribed testosterone among troops. The announcement aligns with broader administration efforts to ease medical access to testosterone for men, including proposed FDA labeling changes.
Defense Secretary Pete Hegseth has announced that the U.S. military will commence a nationwide screening program for testosterone levels among service members.
In a video posted on X titled “High‑T Department,” Hegseth explained that the program is designed to ensure soldiers have “the right testosterone levels to operate at your absolute best,” and that those 30 years and older will be screened annually, while younger troops may request testing.
The protocol will offer voluntary testosterone replacement therapy to men who test low and will maintain a “comprehensive baseline” to sustain a healthy, capable fighting force, according to Pentagon spokesperson Sean Parnell.
Hegseth emphasized that the program is “not about artificial enhancement,” and reminded that taking testosterone without a prescription is strictly forbidden for military personnel.
Dr. Mohit Khera, leading an FDA panel last year, stressed that screening all men over 30 reveals a top marker of future health and that many younger men also experience low testosterone, which can impair muscle, energy, and combat readiness.
Khera cautioned that hormone replacement should be reserved for genuine medical needs, warning that it can cause infertility for men in their reproductive years and potentially increase cardiovascular risk; however, successful therapy can boost muscle mass, reduce fat deposition, lower depression risk, and improve bone density.
The initiative comes amid the administration’s broader push— spearheaded by Health Secretary Robert F. Kennedy Jr –to remove barriers for medical professionals prescribing testosterone. The FDA has recently requested removal of safety and effectiveness language from testosterone product labels and proposed looser prescribing limits.
